Cognitive tests that identify high risk of conversion to dementia in Parkinson's disease.
Myall, D. J.; Horne, K.; MacAskill, M. R.; Livingston, L.; Pitcher, T. L.; Melzer, T. R.; Geurtsen, G. J.; Anderson, T. J.; Dalrymple-Alford, J. C.
Show abstract
BackgroundPeople with Parkinsons disease who meet criteria for mild cognitive impairment are at increased risk of dementia. It is not known which tests are more effective than others for identifying the risk of dementia. MethodsAt baseline, we assessed performance on 21 neuropsychological test measures spanning five cognitive domains in a prospective longitudinal study of 196 non-demented people with Parkinsons. Elastic net logistic regression was used to identify a pair of tests from each cognitive domain that best predicted conversion to dementia over a four year period. The optimal tests most predictive of dementia were also determined when mild cognitive impairment was derived from a logistic-regression classifier that used all 21 measures simultaneously. ResultsWith two tests per domain, the resulting mild cognitive impairment group (N=87/196) captured 44 of 51 individuals who converted to PDD; the out-of-sample relative risk of PDD was 8.0 (95% CI [4.3, 24]), similar to that achieved with the full battery (N=102/196, capturing 45/51, relative risk = 6.9). When selecting tests regardless of domain, there was strong evidence for three tests: Trail Making part B (Executive), Map Search (Attention), and CVLT-II word list acquisition (Episodic Memory). The logistic-regression classifier achieved an out-of-sample AUC of 0.90 [0.84, 0.96] and a relative risk of 12 [6, 39]. ConclusionsAn abbreviated selection of neuropsychological tests can identify non-demented patients who have a high relative risk of progression to PDD.
Matching journals
The top 3 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
- Validation of Serum Neurofilament Light Chain as a Biomarker of Parkinson's Disease Progression 96%
- Neuronal alpha-Synuclein Disease stage progression over five years 96%
- Distinct Longitudinal Clinical-Neuroanatomical Trajectories in Parkinson’s Disease Clinical Subtypes: Insight Towards Precision Medicine 95%
Similar papers in this journal
- Genetic Analysis and Natural History of Parkinson’s Disease Due to the LRRK2 G2019S Variant 95%
- Large-scale genetic characterization of Parkinson’s disease in the African and African admixed populations 95%
- Behavioural changes in frontotemporal dementia and their cognitive and neuroanatomical correlates 93%
Similar papers in this journal
Similar papers in this journal
- A comparison between early presentation of dementia with Lewy Bodies, Alzheimer’s disease and Parkinson’s disease: evidence from routine primary care and UK Biobank data 95%
- Development of Parkinson’s disease and its relationship with incidentally-discovered white matter disease and covert brain infarction in a real world cohort 94%
- Plasma MIA, CRP, and albumin predict cognitive decline in Parkinson’s Disease 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.